Loading viewer...
investor_presentation
Format: PDF investor_presentation
Terumo Blood and Cell Technologies outlines its 5-year growth strategy with a 10-year vision, celebrating the company's 100th founding anniversary. The strategy targets near double-digit revenue growth and adjusted operating profit margins beyond 20% under the GS26 financial aspiration. Terumo aims to provide innovative solutions in blood and cell technologies to improve patient outcomes globally.
investor_presentation
16 Pages
investor_presentation
2 Pages
11 bit studios
HDFC Technology Fund 2023 NFO
investor_presentationinvestor_presentation
38 Pages
HDFC Asset Management